Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC
Accepted 2022-12-14 00:00:00 ET · period of report 2022-12-12 · accession 0001062993-22-023905 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-14 | 2022-12-12+ | COLL | Heffernan Michael Thomas | Dir | S - Sale+OE | $22.14 | -189.6K | 28.0K | -87% | -$4.20M |
| DM | 2022-12-14 | 2022-12-12+ | COLL | Heffernan Michael Thomas | Dir | M - OptEx | $15.10 | +189.6K | 189.7K | +184,084% | +$2.86M |
| DM | 2022-12-14 | 2022-12-12+ | COLL | Heffernan Michael Thomas | Dir | M - OptEx | $0.00 | -189.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-12 | S | D | 27,920 | $22.01 | 28,023 | D | — | — | (F2) The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2). |
| 2 | Common | Common Stock | 2022-12-12 | M | A | 10,669 | $14.90 | 38,692 | D | — | — | |
| 3 | Common | Common Stock | 2022-12-12 | M | A | 15,741 | $15.27 | 54,433 | D | — | — | |
| 4 | Common | Common Stock | 2022-12-12 | M | A | 1,510 | $14.57 | 55,943 | D | — | — | |
| 5 | Common | Common Stock | 2022-12-13 | S | D | 161,687 | $22.16 | 28,023 | D | — | — | (F3) The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). |
| 6 | Common | Common Stock | 2022-12-13 | M | A | 59,524 | $14.90 | 87,547 | D | — | — | |
| 7 | Common | Common Stock | 2022-12-13 | M | A | 94,259 | $15.27 | 181,806 | D | — | — | |
| 8 | Common | Common Stock | 2022-12-13 | M | A | 7,904 | $14.57 | 189,710 | D | — | — | |
| 9 | Derivative | Stock Option (Right to Purchase) | 2022-12-13 | M | D | 7,904 | $0.00 | 0 | D | $14.57 · — to 2029-04-25 | 7,904 Common Stock | (F9) All of the 7,904 option shares are exercisable. |
| 10 | Derivative | Stock Option (Right to Purchase) | 2022-12-13 | M | D | 94,259 | $0.00 | 0 | D | $15.27 · — to 2027-02-10 | 94,259 Common Stock | (F8) All of the 94,259 option shares are exercisable. |
| 11 | Derivative | Stock Option (Right to Purchase) | 2022-12-12 | M | D | 1,510 | $0.00 | 0 | D | $14.57 · — to 2029-04-25 | 1,510 Common Stock | (F6) All of the 1,510 option shares are exercisable. |
| 12 | Derivative | Stock Option (Right to Purchase)t to | 2022-12-12 | M | D | 15,741 | $0.00 | 0 | D | $15.27 · — to 2027-02-10 | 15,741 Common Stock | (F5) All of the 15,741 option shares are exercisable. |
| 13 | Derivative | Stock Option (Right to Purchase) | 2022-12-12 | M | D | 10,669 | $0.00 | 0 | D | $14.90 · — to 2025-05-14 | 10,669 Common Stock | (F4) All of the 10,669 option shares are exercisable. |
| 14 | Derivative | Stock Option (Right to Purchase) | 2022-12-13 | M | D | 59,524 | $0.00 | 0 | D | $14.90 · — to 2025-05-14 | 59,524 Common Stock | (F7) All of the 59,524 option shares are exercisable. |